Research Topics
| Pavel GolubchikSummaryCountry: Israel Publications
| Collaborators
|
Detail Information
Publications
Reboxetine treatment for autistic spectrum disorder of pediatric patients with depressive and inattentive/hyperactive symptoms: an open-label trialPavel Golubchik
Child and Adolescent Outpatient Clinic, Geha Mental Health Center, Petah Tikva, Israel
Clin Neuropharmacol 36:37-41. 2013..Both are often comorbid with autistic spectrum disorder (ASD). We evaluated the effectiveness of reboxetine treatment in pediatric patients with ASD with symptoms of depression and ADHD...- Handshaking as a measure of social responsiveness in patients with autistic spectrum disorderPavel Golubchik
Child and Adolescent Outpatient Clinic, Geha Mental Health Center, Petah Tikva 49100, Israel
Compr Psychiatry 53:805-8. 2012..Unlike eye contact or complex social behavior, this gesture has not been studied in the past. We developed a rating scale intended to evaluate social responsiveness through handshaking, in patients with ASD... - Low-dose quetiapine for adolescents with autistic spectrum disorder and aggressive behavior: open-label trialPavel Golubchik
Geha Mental Health Center, Petah Tikva, Israel
Clin Neuropharmacol 34:216-9. 2011..Atypical antipsychotics may be useful in treating aggression associated with autistic spectrum disorder (ASD). We evaluated the effectiveness of low-dose quetiapine treatment in ASD adolescent patients with aggressive behavior... - Methylphenidate treatment in pediatric patients with attention-deficit/hyperactivity disorder and comorbid trichotillomania: a preliminary reportPavel Golubchik
Child and Adolescent Outpatient Clinic, Geha Mental Health Center, Petah Tikva, Israel
Clin Neuropharmacol 34:108-10. 2011..This study aimed to assess the efficacy and tolerability of methylphenidate (MPH) treatment in children and adolescents who met the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, criteria for both ADHD and TTM... 
Influence of methylphenidate treatment on smoking behavior in adolescent girls with attention-deficit/hyperactivity and borderline personality disordersPavel Golubchik
Geha Mental Health Center, Petah Tikva, Israel
Clin Neuropharmacol 32:239-42. 2009..We assessed the impact of methylphenidate (MPH)treatment on the smoking behavior of adolescent girls with ADHD/borderline personality disorder (BPD)...- Platelet poor plasma serotonin level in delinquent adolescents diagnosed with conduct disorderPavel Golubchik
Geha Mental Health Center, Petah Tikva, Israel
Prog Neuropsychopharmacol Biol Psychiatry 33:1223-5. 2009..The aim of this study was to examine the platelet-poor plasma (PPP) serotonin (5-HT) levels among delinquent adolescent boys with conduct disorder (CD) in comparison with normal controls... - Neurosteroid blood levels in delinquent adolescent boys with conduct disorderPavel Golubchik
Geha Mental Health Center, Petah Tikva, Israel Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Eur Neuropsychopharmacol 19:49-52. 2009..054). DHEA and cortisol levels did not differ between the two groups. The interaction between neurosteroids ( especial DHEA-S) and genetic, developmental and environmental factors in juvenile delinquency merits further investigation... - Methylphenidate in the treatment of female adolescents with cooccurrence of attention deficit/hyperactivity disorder and borderline personality disorder: a preliminary open-label trialPavel Golubchik
Child and Adolescent Outpatient Clinic, Geha Mental Health Center, Petah Tiqva, Israel
Int Clin Psychopharmacol 23:228-31. 2008..5+/-1.3 vs. 1.8+/-0.5, P<0.001). MPH was well tolerated. MPH may be useful and well tolerated in treating some shared symptoms of ADHD and BPD among female adolescents. Controlled studies are needed to substantiate these findings... - Low platelet-poor plasma levels of serotonin in adult autistic patientsBaruch Spivak
Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Neuropsychobiology 50:157-60. 2004..The aim of this study was to determine 5-HT levels in platelet-poor plasma (PPP) in a group of adult patients with autism... - Neurosteroids in child and adolescent psychopathologyPavel Golubchik
Child and Adolescent Outpatient Unit, Geha Mental Health Center, Petah Tiqva, Israel
Eur Neuropsychopharmacol 17:157-64. 2007..The complex interaction between neurosteroids, neurodevelopment, life-events, genetics and mental disorders in children and adolescents merits further investigation... - [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)]Pavel Golubchik
Geha Mental Health Center, Petah Tikva, Israel
Harefuah 150:788-90, 814. 2011..Methylphenidate treatment is recommended in cases when ADHD diagnosis was confirmed. Follow-up is required with special attention to possible cardiovascular, psychiatric and abusive side effects... - The platelet-poor plasma 5-HT response to carbohydrate rich meal administration in adult autistic patients compared with normal controlsYaffa Vered
Laboratory of Clinical Biochemistry, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Hum Psychopharmacol 18:395-9. 2003..Our results indicate that in adult autistic patients, the pattern of PPP 5-HT responsivity to a dietary challenge of CRMT is dysregulated compared with normal controls and provide further support for the role of 5-HT in autism... - Predictors of stress-related growth in parents of children with ADHDRicky Finzi-Dottan
Bar Ilan University, School of Social Work, Ramat Gan 52900, Israel Child and Adolescence Outpatient Clinic, Geha Mental Health Center, Petah Tiqva, P O Box 102, 49100, Israel
Res Dev Disabil 32:510-9. 2011..Path analysis confirmed our research model, suggesting that parents' sense of competence and of parenthood as a challenge vs. a threat mediates between emotional intelligence and social support on the one hand, and growth on the other...